Skip to main content

Gonarthrosis

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Dr. Reddy's Laboratories
1 program
1
Ketorolac TromethaminePhase 41 trial
Active Trials
NCT02638831Completed240Est. Nov 2013
Zimmer Biomet
Zimmer BiometFL - Jacksonville
2 programs
Autologous Protein Solution "APSN/A1 trial
PSIN/A1 trial
Active Trials
NCT01773226Completed11Est. Jun 2014
NCT04114201Completed139Est. Feb 2017
Elekta
ElektaSweden - Stockholm
1 program
Low dose radiotherapy AN/A1 trial
Active Trials
NCT04424628Unknown338Est. Apr 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Dr. Reddy's LaboratoriesKetorolac Tromethamine
ElektaLow dose radiotherapy A
Zimmer BiometAutologous Protein Solution "APS
Zimmer BiometPSI

Clinical Trials (4)

Total enrollment: 728 patients across 4 trials

NCT02638831Dr. Reddy's LaboratoriesKetorolac Tromethamine

Ketorol Gel in Gonarthrosis and Low Back Pain

Start: Mar 2013Est. completion: Nov 2013240 patients
Phase 4Completed
NCT04424628ElektaLow dose radiotherapy A

Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis

Start: May 2019Est. completion: Apr 2023338 patients
N/AUnknown
NCT01773226Zimmer BiometAutologous Protein Solution "APS

Evaluation of Intra-articular Injection of Autologous Protein Solution ("APS(TM)") for the Treatment of Osteoarthritis (OA)

Start: Mar 2013Est. completion: Jun 201411 patients
N/ACompleted
NCT04114201Zimmer BiometPSI

Clinical Outcome and OR Resource Use of Total Knee Arthroplasty Using Patient-Specific or Conventional Instrumentation

Start: Aug 2012Est. completion: Feb 2017139 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.